Biomarkers for Therapeutic Advances in Breast Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 105

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
2. Division of Pathology, IRCCS European Institute of Oncology (IEO), Milan, Italy
Interests: translational research; breast cancer; biomarkers; immunology; molecular pathology; TILs; precision medicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy
2. Department of Oncology, Pisa University Hospital, 56126 Pisa, Italy
Interests: pathology; tumour microenvironment; molecular genetics; breast cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Breast cancer is the second most common cancer in women. The role of novel biomarkers at the genomic, transcriptomic, proteomic, and immunologic levels in treatment decision making for breast cancer is increasing day by day. A deeper investigation of breast cancer-associated novel biomarkers could enhance treatment effectiveness and patient survival.

This Special Issue of Cells, entitled “Biomarkers for Therapeutic Advances in Breast Cancer”, aims to solicit contributions highlighting exciting new findings in the area of biomarkers and therapeutic strategies, together with advanced experimental approaches, for the management of breast cancer.

Authors are welcome to submit comprehensive review articles, original research studies, and communications of preliminary, but significant, experimental results. Each submitted manuscript will undergo a formal peer review process. Submitted manuscripts must not have been published previously, nor can they be under consideration for publication in other journals.

Dr. Nicola Fusco
Dr. Umberto Malapelle
Dr. Cristian Scatena
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast cancer
  • biomarkers
  • therapeutic strategies
  • targeted therapy
  • breast cancer management

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop